Krishna Ghimire

Research activity per year

Fingerprint

Dive into the research topics where Krishna Ghimire is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Finished
6 Active

A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Teclistamab (Tal-Tec), and Inverstigator's Choice in Participants with Relapsed or Refractory Myeloma
Ghimire, K. (PI)
Janssen Research and Development LLC
08/5/24 → 08/4/26
Upstate Medical University
Project: Research
A post authorization safety study to evaluate the incidence of and risk factors for severe and fatal infusion related reactions in participants treated with daratumumab
Ghimire, K. (PI)
Janssen Research and Development LLC
04/22/24 → 04/23/26
Upstate Medical University
Project: Research
A Phase II Study of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia (Protocol No. I-501719)
Ghimire, K. (PI)
Roswell Park Cancer Institute
01/19/24 → 01/18/27
Upstate Medical University
Project: Research
Open label phase 2 single arm study of selinexor, daratumumab, carfilzomib, and dexamethasone for high risk relapsed and elapsed/refratory multiple myeloma patients who have received 1-3 prior lines of therapy
Ghimire, K. (PI)
Karyopharm Therapeutics
02/17/22 → 02/16/27
Upstate Medical University
Project: Research
NRG Oncology Studies
Cunningham, M. (PI), Graziano, S. (PI), Akhtar, K. (CoI), Archer, M. (CoI), Babu, H. (CoI), Basnet, A. (CoI), Benjamin, S. (CoI), Gentile, T. (CoI), Ghimire, K. (CoI), Hahn, S. S. (CoI), Mix, M. (CoI), Pan, D. (CoI), Seth, R. (CoI), Shapiro, A. (CoI), Sivapiragasam, A. (CoI), Thomas, D. (CoI), Li, H. (CoI) & Bogart, J. (CoI)
National Cancer Institute
01/1/21 → 12/31/26
Upstate Medical University
Project: Research

Characterizing KMT2A Rearrangement in Acute Myeloid Leukemia: A Comprehensive Genomic Study
Batayneh, O., Moein, M., Naji, N. S., Patel, A., Mandava, A. R., Goodman, A., Ross, J. S., Ho, C., Marcus, C., Zhou, Z., Kupakuwana-Suk, G., Gentile, T. & Ghimire, K. B., Jan 2026, In: Cancers. 18, 1, 161.
Upstate Medical University
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
A Comprehensive Genomic Analysis of Nucleophosmin (NPM1) in Acute Myeloid Leukemia
Batayneh, O., Moein, M., Goodman, A., Desai, D., Pavlick, D., Marcus, C., Ho, C., Madison, R., Huang, R. S. P., Ross, J. S., Gentile, T., Zhou, Z. & Ghimire, K. B., Aug 2025, In: Cancers. 17, 16, 2710.
Upstate Medical University
Research output: Contribution to journal › Article › peer-review

Open Access
Primary CNS ALK-negative anaplastic large cell lymphoma: A case report and review of the literature
Brady, A. L., Fuller, C. E., Patel, S., Hall, W., Banki, K. & Ghimire, K. B., Jan 2024, In: Radiology Case Reports. 19, 1, p. 393-399 7 p.
Upstate Medical University
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States
Ashok Kumar, P., Ghimire, K., Haroun, E., Kassab, J., Saba, L., Gentile, T., Dutta, D. & Lim, S. H., Mar 2024, In: European Journal of Haematology. 112, 3, p. 328-338 11 p.
Upstate Medical University
Research output: Contribution to journal › Review article › peer-review

Open Access
11 Scopus citations
Intestinal barrier functions in hematologic and oncologic diseases
Haroun, E., Kumar, P. A., Saba, L., Kassab, J., Ghimire, K., Dutta, D. & Lim, S. H., Dec 2023, In: Journal of Translational Medicine. 21, 1, 233.
Upstate Medical University
Research output: Contribution to journal › Review article › peer-review

Open Access
23 Scopus citations

Krishna Ghimire

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Teclistamab (Tal-Tec), and Inverstigator's Choice in Participants with Relapsed or Refractory Myeloma

A post authorization safety study to evaluate the incidence of and risk factors for severe and fatal infusion related reactions in participants treated with daratumumab

A Phase II Study of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia (Protocol No. I-501719)

Open label phase 2 single arm study of selinexor, daratumumab, carfilzomib, and dexamethasone for high risk relapsed and elapsed/refratory multiple myeloma patients who have received 1-3 prior lines of therapy

NRG Oncology Studies

Characterizing KMT2A Rearrangement in Acute Myeloid Leukemia: A Comprehensive Genomic Study

A Comprehensive Genomic Analysis of Nucleophosmin (NPM1) in Acute Myeloid Leukemia

Primary CNS ALK-negative anaplastic large cell lymphoma: A case report and review of the literature

Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States

Intestinal barrier functions in hematologic and oncologic diseases

Krishna Ghimire

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output